A Study to Find Out How Different Forms of BIIB091 is Processed in The Body With and Without Food in Healthy Participants
A Phase 1, Randomized, Open-Label, Single-Dose, 6-Period Crossover Study to Evaluate the Pharmacokinetics of BIIB091 Formulations and the Effect of Food in Healthy Participants
Sponsor: Biogen
A PHASE1 clinical study on Healthy Volunteer, this trial is completed. The trial is conducted by Biogen and has accumulated 4 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
4 versions recorded-
Mar 2025 — Present [monthly]
Completed PHASE1
Status: Recruiting → Completed
-
Jan 2025 — Mar 2025 [monthly]
Recruiting PHASE1
-
Dec 2024 — Jan 2025 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
Nov 2024 — Dec 2024 [monthly]
Not Yet Recruiting PHASE1
First recorded
Oct 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Biogen
For direct contact, visit the study record on ClinicalTrials.gov .